Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Exclusion Criteria

• •Patients have allergies or contraindications (except for thromboembolic disease, liver dysfunction, hypertension, and diabetes) for the involved drugs;
• •Patients have lynch syndrome (LS);
• •Patients have contraindications for pregnancy;
• •Patients have serious underlying disease, malignancies at other site(s), acute liver or kidney disease, acute liver or kidney diseases, acute or subacute genital tract infections and congenital or acquired abnormal uterine development (that may make intrauterine device placement impossible);
• •Patients refuse to participate in clinical follow-up or sign the informed consent form.
• •For Patients With Endometrial atypical hyperplasia：
• •Patients have allergies or contraindications (except for thromboembolic disease, liver dysfunction, hypertension, and diabetes) for the involved drugs
• •Patients have contraindications for pregnancy
• •Patients have serious underlying disease, malignancies at other site(s), acute liver or kidney disease, acute or subacute genital tract infections, and congenital or acquired abnormal uterine development (that may make intrauterine device placement impossible)
• •Patients refuse to participate in clinical follow-up or sign the informed consent form.